tradingkey.logo
搜索

瑞思迈

RMD
添加自选
196.340USD
+5.080+2.66%
收盘 06/24, 16:00美东报价延迟15分钟
28.50B总市值
18.86市盈率 TTM

瑞思迈

196.340
+5.080+2.66%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.66%

5天

+5.39%

1月

-5.63%

6月

-19.68%

今年开始到现在

-18.49%

1年

-23.28%

关键数据
192.910今开
197.600最高
1.67M成交量
18.86市盈率 TTM
16.25市盈率动
2.330股息TTM
1.14%换手率
191.260昨收
192.355最低
180.72M成交额
20.46市盈率静
4.68市净率
1.19%股息率 TTM
18.59%ROA
293.81052周最高
0.90量比
1.40B净利润
145.94M总股本
10.4102每股收益TTM
0.83Beta
25.25%ROE
198.61052周最低
2.74%振幅
61.46%毛利率
28.50B总市值
-5.83回报/风险
1.38%风险率

TradingKey 瑞思迈股票评分

单位: USD 更新时间: 2026-06-24

操作建议

瑞思迈当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名44/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价260.63。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

瑞思迈评分

相关信息

行业排名
44 / 204
全市场排名
111 / 4571
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

瑞思迈亮点

亮点风险
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
业绩高增长
公司营业收入稳步增长,连续3年增长21.86%
利润高增长
公司净利润处于行业前列,最新年度总收入5.15B美元
高分红
公司属于高分红公司,最新股息支付率22.19%
稳定分红
公司5年内连续分红,最新股息支付率22.19%
估值低估
公司最新PE估值18.88,处于3年历史低位
机构减仓
最新机构持股100.10M股,环比减少1.39%
雷·达里奥持仓
明星投资者雷·达里奥持仓,最新持仓市值42.60K
活跃度增加
近期活跃度增加,过去20天平均换手率0.55

分析师目标

根据 21 位分析师
买入
评级
260.634
目标均价
+38.17%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

瑞思迈简介

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
公司代码RMD
公司瑞思迈
CEOFarrell (Michael J)
网址https://www.resmed.com/

常见问题

瑞思迈(RMD)的当前股价是多少?

瑞思迈(RMD)的当前股价是 196.34。

瑞思迈的股票代码是什么?

瑞思迈的股票代码是RMD。

瑞思迈股票的52周最高点是多少?

瑞思迈股票的52周最高点是293.81。

瑞思迈股票的52周最低点是多少?

瑞思迈股票的52周最低点是198.61。

瑞思迈的市值是多少?

瑞思迈的市值是28.65B。

现在瑞思迈(RMD)的股票是买入、持有还是卖出?

根据分析师评级,瑞思迈(RMD)的总体评级为买入,目标价格为260.63。

瑞思迈(RMD)股票的每股收益(EPS TTM)是多少

瑞思迈(RMD)股票的每股收益(EPS TTM)是9.55。
KeyAI